Murphy Analytics Announces Initiation of Coverage on True 2 Beauty, Inc.
October 19 2010 - 8:00AM
Murphy Analytics (MA) has initiated coverage on True 2 Beauty Inc.
(Pink Sheets:TRTB), a California based manufacturer and distributor
of sexual enhancement pills and liquids. The
Initiation Report contains a detailed discussion of TRTB business
operations, market opportunity and competition, macroeconomic data
and indicators, and risks. The Initiation Report is available
at http://www.murphyanalytics.com/uploads/TRTB_Initiation.
Analyst Patrick J. Murphy, CFA notes in the report: "The
acquisition of Libigrow by TRTB was announced on 10/4/10 and the
Company has begun the process of illustrating the market
opportunity and detailing its operating and marketing
strategies. Like many of the products sold by GNC, Vitamin
Shoppe and others, the Food and Drug Administration has not
evaluated the statements made by Libigrow with regard to its
products, and the products are not intended to diagnose, treat,
cure, or prevent, any disease. However, as
evidenced by the success of Enzyte, GNC, Vitamin Shoppe and others,
it seems to be clear that consumers continue to demand dietary
supplement type products in general, with significant growth
appearing to be likely to continue. The opportunity before
TRTB, utilizing an effective marketing and business development
plan, is to build upon the Company's success to date by delivering
more product through existing channels and developing a robust
distribution network."
About Murphy Analytics
Murphy Analytics is an independent investment research firm
providing coverage of microcap and smallcap stocks. Utilizing
institutional caliber, fundamental, bottom-up analysis, Murphy
Analytics helps investors make informed investment decisions about
equities without extensive analyst coverage, with a focus on
small-cap and micro-cap public stocks. Murphy Analytics LLC is
owned by Patrick J. Murphy, who has over 15 years of
capital markets experience, providing institutional
investment and transaction analysis across a range of asset
classes including microcap equities, commercial real estate debt
and equity, municipal derivatives and public finance, venture
capital, fixed income, CMBS and mortgage REIT's.
Disclosure: Murphy Analytics (MA) was
compensated $8,500 in advance of the publication of this
report. Neither MA nor the analyst owns or trades the shares
of covered companies. Statements herein may contain
forward-looking statements and are subject to significant risks and
uncertainties affecting results. MA provides no assurance as to the
subject company's plans or ability to effect proposed actions and
cannot project capabilities, intent, resources, or
experience. This report is neither a solicitation to buy nor
an offer to sell securities and is to be used for informational
purposes only and should not be used as basis for investment
decisions. MA is not an investment advisor or broker/dealer and
this report does not provide investment advice.
CONTACT: Murphy Analytics
Patrick J. Murphy, CFA
636-273-9440
pmurphy@murphyanalytics.com